George Clinical is pleased to confirm the appointment of Mary Gunn as its new Chief Executive Officer. As a global executive, Mary brings to the role extensive experience in high-growth life sciences, financial services, and the education sectors. Mary will also be a director on the Board. Mary Gunn succeeds James Cheong who has served […]
Read MoreRace Oncology Limited recently announce the appointment of George Clinical to support the oncology clinical development of RC220 bisantrene. George Clinical was selected after an extensive and rigorous selection process conducted by the Race Oncology clinical team. In addition to clinical trial expertise, George Clinical, brings access to a supplementary network of key opinion leading […]
Read MoreRace Oncology Limited recently announce the appointment of George Clinical to support the oncology clinical development of RC220 bisantrene. George Clinical was selected after an extensive and rigorous selection process conducted by the Race Oncology clinical team. In addition to clinical trial expertise, George Clinical, brings access to a supplementary network of key opinion leading […]
Read MoreCiteline has named George Clinical as a finalist for their 2021 Clinical Research Team of the Year. Citeline, a comprehensive global R&D intelligence firm provides insights into the global clinical trial landscape and the development of clinical trial programs, selected the DARE-19 team of George Clinical based on their compelling international accomplishments during the height […]
Read MoreOVERLAND PARK, Ks., September 21, 2020 – Dipti Talaulikar, MBBS, PhD, a clinician and researcher with extensive involvement in hematology, has joined George Clinical, a global scientifically-backed clinical research organization, as a member of the organization’s scientific leadership. In addition to her new role as a scientific leader with George Clinical, Dr. Talaulikar is also […]
Read MoreOVERLAND PARK, Ks., April 30, 2020 – George Clinical, a global scientifically-backed clinical research organization, is collaborating with Saint Luke’s Mid America Heart Institute on a new study which will explore whether dapagliflozin (an SGLT inhibitor) can prevent disease progression in patients hospitalized with COVID-19 and at high risk for complications due to pre-existing cardio […]
Read MoreGeorge Clinical Scientific Leader Dr. Lee Schwartzberg has been named among the Best Doctors in America List published by Teladoc. Schwartzberg, based in Memphis, TN, is a member of the scientific leadership team with an oncology focus. Harvard Medical School physicians founded Best Doctors in 1989 as a global benefits provider and medical information services […]
Read MoreThe Indian subcontinent deserves to be considered by pharmaceutical or biotech firms examining clinical trial locations, and veteran industry players may be surprised to learn India is already a leading destination for global clinical trials with significant growth taking place in the biotech sector. Prime opportunities exist for all phases of clinical trials due to […]
Read MoreLast year George Clinical gained recognition by the Mandatory Provident Fund (MPF) legislation for their provision of good MPF benefits in Hong Kong. The Mandatory Provident Fund Schemes Authority (MPFA) awarded George Clinical their Good MPF Employer Award at a ceremony in Hong Kong where Evon Hui, Head of Business Operations, East Asia, accepted the […]
Read MoreSYDNEY, June 17, 2019 – George Clinical, a global scientifically driven CRO, today announced the appointment of Meelian Hoh to the role of Chief Financial Officer. With extensive financial management experience spanning more than 20 years, Hoh brings leadership in financial accountability, enterprise system implementation and pharma industry market knowledge to the George Clinical executive […]
Read More
